EN DE
STOCK COMPARISON

Green Cross Lab Cell vs Thermo Fisher Scientific: Fair Value & Quality

Both stocks run through our valuation models. Here is how Green Cross Lab Cell (144510) and Thermo Fisher Scientific (TMO) compare, as of Aug 11, 2026.

As of Aug 11, 2026, Fair Value Calculator sees Thermo Fisher Scientific as the less overvalued of the two: Green Cross Lab Cell trades at KRW 15,350 versus a fair value of KRW 3,167 (-79%), while Thermo Fisher Scientific trades at $594 versus $308 (-48%).
Green Cross Lab Cell
144510.KQ · KRW · Energy
-79%
upside to fair value
overvalued
PriceKRW 15,350
Fair ValueKRW 3,167
Quality42/100
Thermo Fisher Scientific
TMO · USD · Health Care
-48%
upside to fair value
overvalued
Price$594
Fair Value$308
Quality63/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Green Cross Lab CellThermo Fisher Scientific
Valuation
P/E (TTM)29.5×
P/S (TTM)4.41×
P/B3.74×
EV/EBITDA20.0×
PEG1.74×
Dividend yield0.3%
Dividend per share$1.76
Profitability
-1%Net margin15%
-14%Operating margin18%
-1%Return on equity14%
-2%Return on assets5%
Growth
-6%Revenue growth (YoY)6%
-11.2%Avg. growth/yr (3Y)-0.3%
14.1%Avg. growth/yr (5Y)6.7%
Balance & size
Debt / equity0.67×
$136MMarket cap$199B
mixedGrowth qualityhealthy

Thermo Fisher Scientific leads: 1 to 6 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Green Cross Lab Cellof which business quality 41 · market factors 7 Thermo Fisher Scientificof which business quality 60 · market factors 65
ProfitabilityMargins and returns on capital today
10
43
Quality GrowthAre margins and returns improving?
34
31
CashflowEarnings quality: real cash, not paper profit
17
62
Fin. StrengthBalance sheet, leverage, solvency risk
45
60
InvestmentDisciplined investing over empire-building
97
79
Low VolatilityCalm price path (market factor)
11
68
MomentumPrice trend over the last 3–12 months (market factor)
2
58
52W MomentumDistance to the 52-week high (market factor)
11
72
Net IssuanceBuybacks instead of dilution
82
97

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Green Cross Lab Cell

DCF ModelsKRW 3,333
Dividend DiscountKRW 1,758
MultiplesKRW 1,609
Asset-BasedKRW 8,310
Growth DCFKRW 3,790

12 of 12 models see the stock below the current price.

Thermo Fisher Scientific

DCF Models$354
Earnings-Based$203
Multiples$308
Asset-Based$96.29
Growth DCF$288
Economic Profit$159
Growth Earnings$341

24 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Green Cross Lab Cell
Bear KRW 1,889Fair Value KRW 3,167Bull KRW 4,944
KRW 15,350 = current price (white tick)
Thermo Fisher Scientific
Bear $175Fair Value $308Bull $385
$594 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Green Cross Lab Cell · Energy

Quality score42 · below median
Fair value upside-79% · bottom 25%

Thermo Fisher Scientific · Health Care

Quality score63 · above median
Fair value upside-48% · below median

Bottom line

As of Aug 11, 2026, Fair Value Calculator sees Thermo Fisher Scientific as the less overvalued of the two: Green Cross Lab Cell trades at KRW 15,350 versus a fair value of KRW 3,167 (-79%), while Thermo Fisher Scientific trades at $594 versus $308 (-48%).

Thermo Fisher Scientific has the higher quality score (63/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.